HCPCS Level IIdrugActive
J9393
Inj, fulvestrant (teva)
BETOS: O1E
Effective: 2024-07-01
Description
Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
Medicare Part B Drug Pricing
ASP-Based Payment
This drug code is paid under Medicare Part B using the Average Sales Price (ASP) + 6% methodology.
ASP pricing data not currently available for this code.
Coverage Policies